LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 29 filers reported holding LYRA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $636,783 | +1203.6% | 162,860 | +1270.3% | 0.00% | – |
Q2 2023 | $48,847 | -38.5% | 11,885 | -53.0% | 0.00% | – |
Q4 2022 | $79,385 | -54.4% | 25,282 | -27.1% | 0.00% | – |
Q3 2022 | $174,000 | +77.6% | 34,658 | +54.7% | 0.00% | – |
Q4 2021 | $98,000 | -32.4% | 22,400 | +40.9% | 0.00% | – |
Q3 2021 | $145,000 | -16.2% | 15,895 | -26.2% | 0.00% | – |
Q2 2021 | $173,000 | – | 21,529 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,777,251 | $3,572,275 | 0.74% |
Perceptive Advisors | 9,146,730 | $18,384,927 | 0.54% |
PURA VIDA INVESTMENTS, LLC | 1,996,972 | $4,013,914 | 0.41% |
VR Adviser, LLC | 924,170 | $1,857,582 | 0.36% |
Nantahala Capital Management | 2,220,830 | $4,463,868 | 0.34% |
Ikarian Capital, LLC | 343,685 | $711,427 | 0.16% |
Soleus Capital Management, L.P. | 592,417 | $1,190,758 | 0.12% |
Clearline Capital LP | 119,128 | $239,448 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 146,800 | $303,876 | 0.01% |
Tower Research Capital LLC (TRC) | 9,972 | $20 | 0.00% |